SEARCH

SEARCH BY CITATION

  • 1
    Cavaliere R, Ciocatto EC, Giovanella BC, Heidelburger C, Jonson RO, Margottini M, Mondovi B, Moricca BG, Rossi-Fanelli A. Selective heat sensitivity of cancer cells. Cancer 1967; 20: 135181.
  • 2
    Perez CA, Kopecky W, Rao DV, Baglan R, Mann J. Local microwave hyperthermia and irradiation in cancer therapy: preliminary observations and directions for future clinical trials. Int J Radiat Oncol Biol Phys 1981; 7: 76572.
  • 3
    Gerner EW, Schneider MJ. Induced thermal resistance in HeLa cells. Nature 1975; 256: 5002.
  • 4
    Riabowl KT, Mizzen LA, Welch WJ. Heat shock is lethal to fibroblasts microinjected with antibodies against hsp70. Science 1988; 242: 4336.
  • 5
    Beck SC, Maio A. Stabilization of protein in thermotolerant cells during heat shock. Association of heat shock protein-72 with ribosomal subunits of poly-somes. J Biol Chem 1994; 269: 2180311.
  • 6
    Landry J, Chretien P, Lambert H, Hickey E, Weber LA. Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J Cell Biol 1989; 109: 715.
  • 7
    Mehlen P, Preville X, Chareyron P, Briolay J, Klemenz R, Arrigo AP. Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B-crystallin confers resistance to TNF- and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J Immunol 1995; 154: 36374.
  • 8
    Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. Jpn J Cancer Res 1998; 89: 4639.
  • 9
    Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study. Jpn J Cancer Res 1997; 88: 6302.
  • 10
    Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Jpn J Cancer Res 1998; 89: 77582.
  • 11
    Srivastava PK, MSeAnoret A, Basu S, Binder R, Quade K. Heat shock proteins come of age: primitive functions acquired new roles in an adaptive world. Immunity 1998; 8: 65765.
  • 12
    Ménoret A, Chandawarkar R. Heat-shock protein-based anticancer immuno-therapy: an idea whose time has come. Semin Immunol 1998; 25: 65460.
  • 13
    Castelli C, Ciupitu AM, Rini F, Rivoltini L, Mazzocchi A, Kiessling R, Parmiani G. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. Cancer Res 2001; 61: 2227.
  • 14
    Ito A, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother 2001; 50: 51522.
  • 15
    Yokota S, Kitahara M, Nagata K. Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon. Cancer Res 2000; 60: 29428.
  • 16
    Koishi M, Yokota S, Mae T, Nishimura Y, Kanamori S, Horii N, Shibuya K, Hiraoka M. The effects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo. Clin Cancer Res 2001; 7: 2159.
  • 17
    Shibuya K, Kawasaki S, Kuroda M, Asaumi J, Kanazawa S, Hiraki Y. Effect of PKC inhibitors on suppression of thermotolerance development in tsAF8 cells. Int J Hyperthermia 2001; 17: 10613.
  • 18
    Kitahara O, Furukawa Y, Tanaka T, Kihara C, Ono K, Yanagawa R, Marcelo EN, Takagi T, Nakamura Y, Tsunoda T. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues. Cancer Res 2001; 61: 35449.
  • 19
    Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Borresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclass with clinical implications. Proc Natl Acad Sci USA 2001; 98: 1086974.
  • 20
    Park IK, He Y, Lin F, Laerum OD, Tian Q, Bumgarne R, Klug CA, Li K, Kuhr C, Doyle MJ, Xie T, Schummer M, Sun Y, Goldsmith A, Clarke MF, Weissman IL, Hood L, Li L. Differential gene expression profiling of adult murine hematopoietic stem cells. Blood 2002; 99: 48898.
  • 21
    Sesto A, Navarro M, Burslem F, Jorcano JL. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc Natl Acad Sci USA 2002; 99: 296570.
  • 22
    Tomida S, Hanai T, Honda H, Kobayashi T. Analysis of expression profile using fuzzy adaptive resonance theory. Bioinfomatics 2002; 18: 107383.
  • 23
    Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 148638.
  • 24
    Herwig R, Poustka AJ, Muller C, Bull C, Lehrach H, O'Brien J. Large-scale clustering of cDNA-fingerprinting data. Genome Res 1999; 9: 1093105.
  • 25
    Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES, Golub TR. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 1999; 96: 290712.
  • 26
    MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT. Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits. J Med Chem 1997; 40: 252532.
  • 27
    Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001; 20: 2390400.
  • 28
    O'Brien ML, Cunningham ML, Spear BT, Glauert HP. Peroxisome proliferators do not active the transcription factors AP-1, early growth response-1, or heat shock factors 1 and 2 in rats or hamsters. Toxicol Sci 2002; 69: 13948.
  • 29
    Guo YL, Chang HC, Tsai JH, Huang JC, Li C, Young KC, Wu LW, Lai MD, Liu HS, Huang W. Two UVC-induced stress response pathways in HeLa cells identified by cDNA microarray. Environ Mol Mutagen 2002; 40: 1228.
  • 30
    Liu C, Rangnekar VM, Adamson E, Mercola D. Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther 1998; 5: 328.
  • 31
    Chuang YY, Chen Y, Gadisetti C, Chandramouli VR, Cook JA, Coffin D, Tsai MH, Degraff W, Yan H, Zhao S, Russo A, Liu ET, Mitchell JB. Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hy-droperoxide in breast cancer cells. Cancer Res 2002; 62: 624654.
  • 32
    Werner RM, Jiang YL, Gordley RG, Jagadeesh GJ, Ladner JE, Tordova M, Gilliland GL, Stivers JT. Stressing-out DNA; the contribution of serine-phosphodiester interactions in catalysis by uracil DNA glycosylase. Biochemistry 2000; 39: 1258594.
  • 33
    Buckbinder L, Velasco-Miguel S, Chen Y, Xu N, Talbott R, Gelbert L, Gao J, Seizinger BR, Gutkind JS, Kley N. The p53 tumor suppressor targets a novel regulator of G protein signaling. Proc Natl Acad Sci USA 1997; 94: 786872.
  • 34
    Fiscella M, Zhang HL, Fan S, Sakaguchi K, Shen S, Mercer WE, Woude V, O'Connor PM, Appella E. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc NatlAcadSci USA 1997; 94: 604853.
  • 35
    Zucker S, Cao J, Chen WT. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000; 19: 664250.
  • 36
    Hoekstra R, Eskens FA, Verwij J. Matrix metalloproteinase inhibitors: current developments and future perspectives. Oncologist 2001; 6: 41527.
  • 37
    Kregel KC. Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol 2002; 92: 217786.
  • 38
    Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 30: 214914.
  • 39
    Reuben PM, Brogley MA, Sun Y, Cheung HS. Molecular mechanisms of the induction of metalloproteinases 1 and 3 in human fibroblasts by basic calcium phosphate crystals. Role of calcium-dependent protein kinase C alpha. J Biol Chem 2002; 277: 151908.
  • 40
    Reunanen N, Li SP, Ahonen M, Foschi M, Han J, Kahari VM. Activation of p38 alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. J Biol Chem 2002; 277: 323608.
  • 41
    Matsuzawa K, Fukuyama K, Dirks PB, Hubbard S, Murakami M, Becker LE, Rutka JT. Expression of stromelysin 1 in human astrocytoma cell lines. J Neurooncol 1996; 30: 1818.
  • 42
    Vance BA, Kowalski CG, Brinckerhoff CE. Heat shock of rabbit synovial fibroblasts increases expression of mRNAs for two metalloproteinases, collagenase and stromelysin. J Cell Biol 1989; 108: 203743.
  • 43
    Sato T, Sawaji Y, Matsui N, Sato H, Seiki M, Mori Y, Ito A. Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion. Biochem Biophys Res Commun 1999; 265: 18993.
  • 44
    Reinermer P, Grams F, Huber R, Kleine T, Schnierer S, Piper M, Tschesche H, Bode W. Structural implications for the role of the N terminus in the ‘superactivation’ of collagenases. A crystallographic study. FEBS Lett 1994; 338: 22733.
  • 45
    Crabbe T, Willenbrock F, Eaton D, Hynds P, Carne AF, Murphy G, Docherty AJ. Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases. Biochemistry 1992; 31: 85007.
  • 46
    Levitt NC, Eskens FALM, O'Byrne KJ, Propper DJ, Denis LJ, Owen SJ, Choi L, Foekens JA, Wilner S, Wood JM, Nakajima M, Talbot DC, Steward WP, Harris AL, Verweij J. Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer. Clin Cancer Res 2001; 7: 19121922.